Rodetis will also continue to serve as the company's treasurer.
Global medical technology company Becton, Dickinson and Company (BD) announced that it has appointed Gred Rodetis as senior vice president of investor relations.
Rodetis will also continue to serve in his role as treasurer.
In a press release, BD chief financial officer and executive vice president Chris DelOrefice said, “Greg's deep knowledge of BD, coupled with his expertise of the capital markets and existing relationships with the investment banking community, make him well-positioned to lead our investor relations function and serve as a valued partner to this important stakeholder group as BD continues to deliver on its growth strategy.”
SOURCE
(October 17, 2023); BD (Bection, Dickinson and Company); BD Names Greg Rodetis as Senior Vice President of Investor Relations; https://www.prnewswire.com/news-releases/bd-names-greg-rodetis-as-senior-vice-president-of-investor-relations-301958983.html
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.